Katherine is a Market Access specialist with more than 10 years of experience in international research and consulting firms. She has managed various Pricing, Reimbursement, and Market Access projects across multiple therapeutic areas and geographical markets, particularly the major markets in Europe. She has advised pharmaceutical and medical device clients regarding European Market Access pathways and policies.
She has also helped them in evaluating the price and reimbursement potential, drivers and barriers of their products, evidence planning and generation, and has developed strategies to successfully enter the market based on a comprehensive analysis of the environment, in-depth market knowledge, and payer insights.  

Katherine is a Biologist and a board-certified Medical Doctor. She holds a MSc in Health Care Systems and a MSc in Health Economics (Economic Evaluation for HTA).